Coulon S. et al. (2013) have found that high fat diet-induced steatosis and NASH were successfully resolved upon treatment with anti-VEGFR-2 antibodies (DC101) [87]. Here, KDR is linked to metabolic dysfunction-associated steatohepatitis.